TriMas (NASDAQ:TRS) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

TriMas (NASDAQ:TRS - Get Free Report) issued its quarterly earnings results on Tuesday. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.03, Zacks reports. The firm had revenue of $241.67 million for the quarter, compared to analyst estimates of $235.41 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The company's revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.37 earnings per share. TriMas updated its FY 2025 guidance to 1.700-1.850 EPS.

TriMas Stock Up 2.3 %

Shares of NASDAQ TRS traded up $0.55 during midday trading on Friday, hitting $24.75. 407,166 shares of the stock traded hands, compared to its average volume of 319,868. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. TriMas has a one year low of $19.33 and a one year high of $28.51. The business has a 50 day moving average price of $22.47 and a two-hundred day moving average price of $24.28. The company has a market cap of $1.01 billion, a PE ratio of 38.67 and a beta of 0.58.

TriMas Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th will be paid a $0.04 dividend. The ex-dividend date of this dividend is Tuesday, May 6th. This represents a $0.16 dividend on an annualized basis and a yield of 0.65%. TriMas's dividend payout ratio (DPR) is presently 20.78%.

Insider Activity at TriMas

In other news, Director Shawn Sedaghat bought 249,597 shares of TriMas stock in a transaction dated Friday, March 7th. The stock was purchased at an average price of $23.83 per share, for a total transaction of $5,947,896.51. Following the purchase, the director now directly owns 346,825 shares in the company, valued at $8,264,839.75. The trade was a 256.71 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jeffrey A. Fielkow purchased 2,500 shares of the company's stock in a transaction that occurred on Friday, February 28th. The shares were purchased at an average cost of $20.78 per share, for a total transaction of $51,950.00. Following the completion of the transaction, the director now directly owns 11,013 shares of the company's stock, valued at $228,850.14. This represents a 29.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 929,634 shares of company stock valued at $22,278,549. 14.20% of the stock is owned by company insiders.

Analyst Ratings Changes

Separately, BWS Financial restated a "buy" rating and issued a $40.00 price target on shares of TriMas in a report on Wednesday.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.